Median Technologies forms strategic review committee, names Oern Stuge chair

Reuters2026/09/02 15:45

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Median Technologies created a Strategic Review Committee to assess structural and financial options to lift shareholder value.
Scope includes a potential separation of iCRO from eyonis, potential U.S. listing, other strategic alternatives.
Oern Stuge will chair the committee; the former Medtronic executive has led EMEA and emerging markets, cardiac surgery businesses.
A new board-level R&D Committee will oversee scientific priorities and the expansion of the eyonis platform beyond lung cancer screening.
Kapil Dhingra will chair the R&D Committee; he previously led oncology clinical development at Roche, worked at MD Anderson.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Median Technologies SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260902298041) on September 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Median Technologies forms strategic review committee, names Oern Stuge chair

You may also like

Crypto prices